Skip to content

Clinical trials

Phase 1 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1 Clear all

55,368 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
2000264
2001323
2002425
2003552
2004812
20051,011
20061,296
20071,585
20081,852
20092,104
20102,171
20112,193
20122,041
20132,093
20142,392
20152,273
20162,321
20172,362
20182,490
20192,643
20202,703
20213,089
20222,999
20232,937
20243,048
20253,041
20262,862

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35,480
Recruiting4,898
Unknown status4,608
Terminated4,405
Active, not recruiting1,949
Withdrawn1,837
Not yet recruiting1,789
Suspended220
Enrolling by invitation182

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer1,117
Boehringer Ingelheim1,063
GlaxoSmithKline1,043
AstraZeneca967
National Cancer Institute (NCI)959
National Institute of Allergy and Infectious Diseases (NIAID)827
Eli Lilly and Company789
Merck Sharp & Dohme LLC640
M.D. Anderson Cancer Center557
Bristol-Myers Squibb484

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms2,151
Breast Neoplasms1,412
Carcinoma, Non-Small-Cell Lung1,300
Diabetes Mellitus, Type 21,041
Leukemia, Myeloid, Acute1,037
Neoplasm Metastasis946
HIV Infections857
Melanoma838
Multiple Myeloma829
Colorectal Neoplasms826

Trials

Showing 51 to 75 of 55,368. Each trial links to its page on Pharma Observatory.

55,268 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.